Clin2
NCT07643870Possibly a fitNot yet recruiting

Study of a new pill for advanced solid tumors

Advanced Solid Malignancies

Treatments studied

Part of Cancer clinical trials.

This trial tests an investigational pill for people with advanced or spreading solid tumors. It aims to see if the drug is safe and effective, and may be an option if standard treatments have not worked.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
8 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You must have a confirmed solid tumor that is advanced or has spread.
  • You should be able to care for yourself and be up and about (performance status 0 or 1).
  • Your kidneys and liver must be working well enough.
  • You must be able to swallow pills and have regular bowel movements.
  • You should not have had significant weight loss due to cancer (cachexia).
  • You must not have certain heart, lung, or muscle conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06600789Recruiting· Phase 1/Phase 2
Testing a new drug for advanced solid tumors

This trial is testing whether a new drug called CT7439 can help people with advanced solid tumors that have not responded to other treatments. It is a phase 1/2 study that also checks the drug's safety and how well it works.

Dallas, Texas
NCT07115043Recruiting· Phase 1/Phase 2
Study of AZD6750 for advanced solid tumors

This trial tests a new drug called AZD6750 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.

Grand Rapids, Michigan
NCT06787950Not yet recruiting· Phase 1/Phase 2
New pill for advanced solid tumors that have stopped responding to other treatments

This trial tests a new pill called ASN-3186 for people with advanced solid tumors that haven't responded to standard treatments. The drug may work especially well if your cancer has certain DNA repair problems, like a BRCA mutation.

NCT06005493Recruiting· Phase 1/Phase 2
Study of a new drug for advanced stomach, esophagus, or pancreas cancer

This trial tests a new medication that targets a specific protein (CLDN18.2) found on some cancer cells. It may help people with advanced or metastatic stomach, esophageal, or pancreatic cancer who have already tried other treatments.

Jacksonville, Florida
NCT07038343Recruiting· Phase 1/Phase 2
Testing a new drug for advanced solid tumors

This trial tests a new drug called AVZO-1418, either alone or with other treatments, for people with advanced solid tumors that have spread or cannot be removed. The goal is to see if the drug is safe and effective against certain types of cancer.

Gilbert, Arizona
NCT07811297Not yet recruiting· Phase 1/Phase 2
Experimental pill for advanced sarcomas and other solid tumors

This trial tests an experimental pill for several advanced cancers, including soft tissue sarcoma, endometrial cancer, low-grade ovarian cancer, and glioblastoma. The goal is to see how safe the drug is and if it can slow down or shrink tumors.

Houston, Texas

Hear when a new Advanced Solid Malignancies trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.